Credit Suisse Group AG Reaffirms Underperform Rating for AstraZeneca plc

Credit Suisse Group AG Reaffirms Underperform Rating for AstraZeneca plc


's stock had its "underperform" rating reaffirmed by research analysts at Credit Suisse Group AG in a report released on Friday. They currently have a GBX 4,000 target price on the biopharmaceutical company's stock.



from Biotech News